Updated:
POINT Biopharma Global Inc.
POINT Biopharma Global Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811764, and its reported...
Overview
POINT Biopharma Global Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811764, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-27, it reported annual revenue of USD 226,579,563; net income of USD 98,293,213; total assets of USD 578,322,736 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- POINT Biopharma Global Inc.
- Former names in filing history
- Therapeutics Acquisition Corp. (2020-05-14 to 2021-06-30)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Indianapolis, IN, United States
- Fiscal year end
- December 31
- SEC CIK
- 0001811764
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $226.6M | $98.3M | $578.3M | $286.4M | $183.5M | |
| FY2021USD | — | -$45.9M | $263.3M | $238.8M | -$44.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| SC 13D | — | SCHEDULE 13D | |
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research POINT Biopharma Global Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.